
Biofrontera AG BFRA
Biofrontera AG ROCE 2011-2025 | BFRA
ROCE Jährlich Biofrontera AG
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| -15.82 | -49.97 | -58.92 | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -15.82 | -58.92 | -41.57 |
ROCE anderer Aktien in der Pharmaeinzelhändler
| Name | ROCE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Arbutus Biopharma Corporation
ABUS
|
-73.67 | $ 4.9 | 4.03 % | $ 813 M | ||
|
MorphoSys AG
MOR
|
2.89 | - | 2.43 % | $ 254 M | ||
|
Aclaris Therapeutics
ACRS
|
-91.24 | $ 3.21 | -1.38 % | $ 248 M | ||
|
AlloVir
ALVR
|
-57.76 | - | 4.14 % | $ 49.1 M | ||
|
Aptevo Therapeutics
APVO
|
-517.39 | $ 1.06 | -6.22 % | $ 293 K | ||
|
Catalyst Biosciences
CBIO
|
424.75 | $ 13.33 | -5.39 % | $ 878 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
17.36 | - | - | $ 40.3 B | ||
|
Ascendis Pharma A/S
ASND
|
-45.89 | $ 214.55 | -2.66 % | $ 5 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-61.36 | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
-337.43 | - | -18.52 % | $ 27.3 M | ||
|
Alterity Therapeutics Limited
ATHE
|
-104.38 | $ 3.1 | -5.93 % | $ 7.46 B | ||
|
Celldex Therapeutics
CLDX
|
-26.11 | $ 27.09 | -1.53 % | $ 1.74 M | ||
|
Corcept Therapeutics Incorporated
CORT
|
20.15 | $ 88.51 | 0.59 % | $ 9.14 B | ||
|
Catalyst Pharmaceuticals
CPRX
|
26.82 | $ 24.35 | 3.07 % | $ 2.88 B | ||
|
Biophytis SA
BPTS
|
-325.06 | - | -13.47 % | $ 169 M | ||
|
CureVac N.V.
CVAC
|
-51.5 | $ 5.02 | -0.59 % | $ 934 M | ||
|
Институт стволовых клеток человека
ISKJ
|
15.18 | - | - | - | ||
|
BioVie
BIVI
|
-95.03 | $ 1.43 | -1.72 % | $ 2.11 M | ||
|
ARCA biopharma
ABIO
|
-23.06 | - | 1052.0 % | $ 415 M | ||
|
Acasti Pharma
ACST
|
-25.04 | - | 4.01 % | $ 150 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
-353.66 | - | -15.15 % | $ 60.3 M | ||
|
BioNTech SE
BNTX
|
-4.81 | $ 93.99 | -0.86 % | $ 27.2 B | ||
|
Aeglea BioTherapeutics
AGLE
|
-40.28 | - | - | $ 1.01 B | ||
|
Dynavax Technologies Corporation
DVAX
|
-0.69 | $ 10.88 | 0.74 % | $ 1.41 B | ||
|
Albireo Pharma
ALBO
|
-70.32 | - | -0.23 % | $ 916 M | ||
|
Alpine Immune Sciences
ALPN
|
-32.41 | - | - | $ 2.17 B | ||
|
Ampio Pharmaceuticals
AMPE
|
-75.24 | - | -11.43 % | $ 502 K | ||
|
Amphastar Pharmaceuticals
AMPH
|
28.05 | $ 26.44 | 4.63 % | $ 1.28 B | ||
|
Applied Molecular Transport
AMTI
|
-209.11 | - | - | $ 10.1 M | ||
|
Anika Therapeutics
ANIK
|
-41.29 | $ 9.6 | 0.42 % | $ 141 M | ||
|
Eton Pharmaceuticals
ETON
|
-7.7 | $ 15.97 | -4.37 % | $ 410 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-115.03 | $ 0.26 | -6.9 % | $ 566 M | ||
|
Evogene Ltd.
EVGN
|
-39.87 | $ 1.04 | -3.7 % | $ 27.9 M | ||
|
Exelixis
EXEL
|
26.94 | $ 41.27 | 0.95 % | $ 12 B | ||
|
Arena Pharmaceuticals
ARNA
|
-92.73 | - | -6.81 % | $ 3.04 B | ||
|
Athersys
ATHX
|
-531.85 | - | 3.77 % | $ 22.4 M | ||
|
Acer Therapeutics
ACER
|
146.85 | - | 2.71 % | $ 14 M | ||
|
Avenue Therapeutics
ATXI
|
-403.4 | - | -52.27 % | $ 4.45 M | ||
|
Foghorn Therapeutics
FHTX
|
225.54 | $ 4.39 | -1.13 % | $ 241 M | ||
|
AVROBIO
AVRO
|
10.76 | - | 1083.1 % | $ 745 M | ||
|
Axon Enterprise
AXON
|
2.51 | $ 551.37 | -2.29 % | $ 41.8 B | ||
|
Ayala Pharmaceuticals
AYLA
|
3412.47 | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
-12.81 | $ 2.35 | 2.17 % | $ 14.8 M | ||
|
AstraZeneca PLC
AZN
|
11.12 | $ 91.19 | 1.51 % | $ 96.9 B | ||
|
Acorda Therapeutics
ACOR
|
167.74 | - | -24.86 % | $ 820 K | ||
|
Brickell Biotech
BBI
|
-64.05 | - | -5.38 % | $ 6.06 M | ||
|
Burford Capital Limited
BUR
|
14.24 | $ 8.88 | -1.33 % | $ 1.45 B | ||
|
BeiGene, Ltd.
BGNE
|
-15.33 | - | 0.49 % | $ 251 B | ||
|
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
95.22 | $ 11.25 | -2.43 % | $ 728 M | ||
|
Biogen
BIIB
|
31.45 | $ 174.69 | 0.34 % | $ 25.4 B |